Jaguar Health, Inc. announced the appointment of Karen J. Brunke, Ph.D., a microbiologist and pharmaceutical industry veteran, to the role of Executive Vice President of Corporate and Business Development. Jaguar also announced the appointment of Chip Whitlow, a seasoned veteran of the animal and human health pharmaceutical arenas, as Marketing Director for the Company's animal health commercial products portfolio. Dr. Brunke brings to Jaguar over 30 years of scientific, operational, clinical, senior executive, and corporate development experience in both large and small biotechnology companies. Following her post-doctoral fellowship at the Institute for Cancer Research in Fox Chase, Dr. Brunke joined the seeds division of Sandoz, with her most recent position having been Research Director, overseeing a department whose successes included recombinant insect-resistant plants (GMOs) which have been an important backbone for the greater than $3 billion seed business of the now Syngenta Seeds.